HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors

NCT05360368 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Henlius Biotech